Join host, Dr. Roberto Pecoits-Filho, and Dr. Catherine Clase as they discuss the benefits of RASi utilization. Additional topics include:
The role of RASi in the management of CKD progression
Outcomes
ACE / ARBs
Is RASi underutilized? Is it worth not to discontinue?
The impact of the KDIGO Blood Pressure Management in CKD Guideli ... Show More
Jun 2024
Season 4 Episode 5: PDOPPS International Study of Practice Patterns and Outcomes of Peritoneal Dialysis Patients
This latest episode of the Global Kidney Care Podcast is an effort of the ISN, ISPD, and Arbor Research Collaborative for Health (the coordinating center for the DOPPS family of studies). This episode is focused on PDOPPS, our international study of practice patterns and outcomes ... Show More
37m 33s
Mar 2023
Renal Replacement Therapies
Dr. Staci Leisman, Associate Professor of Medicine and Medical Education at the Icahn School of Medicine at Mount Sinai, joins us to discuss renal replacement therapies. With host Dr. Emily Gutowski, she works through several cases that highlight the different types of RRT, advan ... Show More
27m 26s
May 2024
HCM Practice Essentials: Patient and Family Support
In this episode, Prof Juan Pablo Kaski is joined by Dr Jodie Ingles and Dr Elena Biagini to discuss long-term management, expectations in cardiology, community care and family genetic screening. Tune in for expert insights on supporting patients and their families.
24m 43s
Jun 2024
HCM Practice Essentials: Management Essentials
In this episode, Prof Juan Pablo Kaski is joined by Dr Carolyn Ho, join them in this 20-minute discussion on essential management topics, including phenotyping, triaging, symptomatic care, and transplant considerations.
27m 24s
Mar 2025
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab
Interview with Arshad M. Khanani, MD, author of Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial. Hosted by Neil Bressler, MD. Related Content: Continuous Ranibizumab via Port Deli ... Show More
23m 43s